Vascular endothelial growth factor 121 is the predominant isoform in psoriatic scales

Experimental Dermatology

Volumn 14, Issue 10, 2005, Pages 758-764

  Zhang, Yan ^a   Matsuo, Hiroaki ^a   Morita, Eishin ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Psoriasis; Scale; VEGF

Indexed keywords

SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PSORIASIS VULGARIS; STRATUM CORNEUM; UMBILICAL VEIN; WESTERN BLOTTING;

CELLS, CULTURED; CHROMATOGRAPHY, GEL; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN ISOFORMS; PSORIASIS; RECOMBINANT PROTEINS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 26444569249     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2005.00356.x     Document Type: Article

References (28)

1. Telner P, Fekete Z. The capillary responses in psoriatic skin. J Invest Dermatol 1961: 36: 225-230.
2. Malhotra R, Stenn K S, Fernandez L A, Braverman I M. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest 1989: 61: 162-165.
3. Braverman I M, Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol 1977: 68: 53-60.
4. Braverman I M, Sibley J. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 1982: 78: 12-17.
5. Schubert C, Christophers E. Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 1985: 277: 352-358.
6. Barnhill R L, Parkinson E K, Ryan T J. Supernatants from cultured human epidermal keratinocytes stimulate angiogenesis. Br J Dermatol 1984: 110: 273-281.
7. Brody I. Dermal and epidermal involvement in the evolution of acute eruptive guttate psoriasis vulgaris. J Invest Dermatol 1984: 82: 465-470.
8. Detmar M, Yeo K T, Nagy J A et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995: 105: 44-50.
9. Houck K A, Ferrara N, Winer J, Cachianes G, Li B, Leung D W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991: 5: 1806-1814.
10. Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor. J Biol Chem 1991: 266: 11947-11954.
11. 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 1997: 272: 7151-7158.
12. Lei J, Jiang A, Pei D. Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF 183. Biochim Biophys Acta 1998: 1443: 400-406.
13. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 1995: 104: 7-10.
14. Detmar M, Brown L F, Claffey K P et al. Over-expression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994: 180: 1141-1146.
15. Tagami H, Ofuji S. Leukotactic properties of soluble substances in psoriasis scale. Br J Dermatol 1976: 95: 1-8.
16. Bhushan M, McLaughlin B, Weiss J B, Griffiths C E M. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 1999: 141: 1054-1060.
17. Ferrara N, Houck K, Jakeman L, Leung D W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992: 13: 18-32.
18. Senger D R, Peruzzi C A, Feder J, Dvorak H F. A highly conserved vascular permeability factor secreted by a variety of human and rodent cell lines. Cancer Res 1986: 46: 5629-5632.
19. Frank S, Hubner G, Breier G, Longaker M T, Greenhalgh D G, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 1995: 270: 12607-12613.
20. Scalise A, Tucci M G, Lucarini G et al. Local rh-VEGF administration enhances skin flap survival more than other types of rh-VEGF administration: a clinical, morphological and immunohistochemical study. Exp Dermatol 2004: 13: 682-690.
21. Keyt B A, Berleau L T, Nguyen H V et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996: 271: 7788-7795.
22. Oshika Y, Nakamura M, Tokunaga T et al. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol 1998: 12: 541-544.
23. Tokunaga T, Oshika Y, Abe Y et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 1998: 77: 998-1002.
24. Lee Y H, Tokunaga T, Oshika Y et al. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999: 35: 1089-1093.
25. Kusters B, de Waal R M W, Wesseling P et al. Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma. Cancer Res 2003: 63: 5408-5413.
26. Pinkus H, Mehregan A H. The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol 1966: 46: 109-116.
27. Morita F, Kameyoshi Y, Hiragun T, Mihara S, Yamamoto S. The C-C chemokines, RANTES and eotaxin, in atopic dermatitis. Allergy 2001: 56: 194-195.
28. Morita E, Hiragun T, Mihara S et al. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis. J Dermatol Sci 2004: 34: 237-240.